Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Stanford Translational Research Integrated Database Environment and Clinical Data Warehouse Resource Report Resource Website |
Stanford Translational Research Integrated Database Environment and Clinical Data Warehouse (RRID:SCR_003453) | STRIDE and the CDW, STRIDE | data or information resource, standard specification, narrative resource, software resource | Research and development project at Stanford University to create a standards-based informatics platform supporting clinical and translational research. STRIDE consists of three integrated components: a clinical data warehouse, based on the HL7 Reference Information Model (RIM), containing clinical information on over 1.6 million pediatric and adult patients cared for at Stanford University Medical Center since 1995; an application development framework for building research data management applications on the STRIDE platform and a biospecimen data management system. STRIDE's semantic model uses standardized terminologies, such as SNOMED, RxNorm, ICD and CPT, to represent important biomedical concepts and their relationships. STRIDE receives clinical data for research use via HL7 feeds from both SUMC hospitals: Lucile Packard Children's Hospital and Stanford Hospital and Clinics. This clinical data is used to support a wide variety of translational research services including: * Anonymized Patient Research Cohort Discovery * Electronic Chart Review for Research * IRB-Approved Clinical Data Extraction * Biospecimen Data Management * Multimedia Research * Data Management and Research Registries STRIDE is a highly secure environment utilizing encryption, fine-grained access control, robust auditing and detailed data segregation. Additionally, STRIDE has a robust access control framework with well-defined access granting authorities and access control groups. Consequently STRIDE meets or exceeds the requirements of the HIPAA Privacy and Security regulations. Privacy protection is further enhanced by requiring IRB approval for all research projects using STRIDE clinical data. From a technology and standards perspective, STRIDE is hosted on the Oracle 11g database platform. STRIDE application software provides access to the web services of a three-tier infrastructures using SSL encryption with strong authentication. These programs are cross-platform, self-updating thick-client applications that provides a rich user interface for data entry, retrieval and review as well as image manipulation and annotation. STRIDE makes extensive use of XML technologies for representation of structured meta data, distributed systems technologies using JSON for secure remote communication between client and server, and Swing graphical interface components providing a rich widget-set as well as advanced imaging and graphing capabilities. Users of the STRIDE Research Desktop Client can perform rapid data entry into structured fields, compose complex queries, and interact securely with clinical, research and imaging data. | clinical, hospital, research, translational, informatics, platform, database, pediatric, adult, data management, biospecimen, ctsa, clinical data, oracle, image, imaging data |
is listed by: Biositemaps has parent organization: Stanford University; Stanford; California is parent organization of: STRIDE Virtual Biospecimen Bank |
PMID:20351886 | Free, Freely available | nif-0000-33359 | https://med.stanford.edu/irt/researchtech.html | SCR_003453 | STRIDE and the Clinical Data Warehouse, STRIDE Clinical Data Warehouse | 2026-02-16 09:46:08 | 0 | |||||
|
Accelerating Medicines Partnership - Alzheimers Resource Report Resource Website |
Accelerating Medicines Partnership - Alzheimers (RRID:SCR_003742) | AMP Alzheimer's, AMP Alzheimer's Disease | data or information resource, organization portal, consortium, portal | The Alzheimer's disease arm of the Accelerating Medicines Partnership (AMP) that will identify biomarkers that can predict clinical outcomes, conduct a large scale analysis of human AD patient brain tissue samples to validate biological targets, and to increase the understanding of molecular pathways involved in the disease to identify new potential therapeutic targets. The initiative will deposit all data in a repository that will be accessible for use by the biomedical community. The five year endeavor, beginning in 2014, will result in several sets of project outcomes. For the biomarkers project, tau imaging and EEG data will be released in year two, as baseline data becomes available. Completed data from the randomized, blinded trials will be added after the end of the five year studies. This will include both imaging data and data from blood and spinal fluid biomarker studies. For the network analysis project, each project will general several network models of late onset AD (LOAD) and identify key drivers of disease pathogensis by the end of year three. Years four and five will be dedicated to validating the novel targets and refining the network models of LOAD, including screening novel compounds or drugs already in use for other conditions that may have the ability to modulate the likely targets. | drug, drug development, biomarker, data sharing, consortium, disease target, drug design, brain tissue, brain, tissue, clinical, neuroimaging, tau, blood, cerebral spinal fluid, eeg, clinical trial, amyloid beta, neurofibrillary tangle |
is listed by: Consortia-pedia is related to: Accelerating Medicines Partnership Autoimmune Diseases of Rheumatoid Arthritis and Lupus is related to: Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) is related to: Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) is related to: Accelerating Medicines Partnership Autoimmune Diseases of Rheumatoid Arthritis and Lupus has parent organization: Foundation for the National Institutes of Health has parent organization: Accelerating Medicines Partnership |
NIH ; Industry partners |
nlx_157974 | SCR_003742 | Accelerating Medicines Partnership - Alzheimer's Disease, Accelerating Medicines Partnership - Alzheimer's, Accelerating Medicines Partnership Alzheimer's Disease | 2026-02-16 09:46:14 | 0 | |||||||
|
Center for Integration of Medicine and Innovative Technology Resource Report Resource Website 1+ mentions |
Center for Integration of Medicine and Innovative Technology (RRID:SCR_003710) | CIMIT | funding resource, organization portal, consortium, portal, data or information resource | A non-profit consortium of Boston academic medical centers and universities (and growing) to accelerate the healthcare innovation cycle by fostering interdisciplinary, inter-institutional collaboration among experts in translational research, medicine, science, engineering, healthcare implementation and entrepreneurship in concert with industry, foundations and government to rapidly improve patient care. It concentrates on early stage, high-risk ideas, projects and supports them through to a commercial exit from academia. It provides innovators with resources to explore, develop and implement novel technological solutions for today's most urgent healthcare problems. CIMIT is dedicated to helping develop medical technology that will help both military and civilian patients. | device, procedure, diagnosis, healthcare, consortium, clinical, systems engineering, technology, patient care, translational research, medicine, science, engineering, innovation, consortium |
is listed by: Consortia-pedia has parent organization: Massachusetts Institute of Technology; Massachusetts; USA; has parent organization: Charles Stark Draper Laboratory |
United States Department of Defense ; Membership fees ; NIBIB |
nlx_157880 | SCR_003710 | Center for Integration of Medicine & Innovative Technology, Center for Integration of Medicine and Innovative Technology (CIMIT) | 2026-02-16 09:46:13 | 5 | |||||||
|
AtheroRemo Resource Report Resource Website 1+ mentions |
AtheroRemo (RRID:SCR_003831) | AtheroRemo | data or information resource, organization portal, consortium, portal | Project targeting vulnerable plaques causing unexpected acute myocardial infarcts and sudden cardiac deaths by identifying and validating novel drug targets as well as devising and validating diagnostic tests. It has been designed to advance the present knowledge on the role of inflammatory remodeling in the different stages of atherosclerosis. It will also provide important knowledge for the development of strategies for prevention and clinical management of vascular diseases. | consortium, drug target, diagnostic test, clinical, plaque, inflammation, functional genomics, target validation, lipidomics | is listed by: Consortia-pedia | European Union FP7 | nlx_158144 | SCR_003831 | AtheroRemo Consortium, European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis - AtheroRemo | 2026-02-16 09:46:12 | 1 | |||||||
|
Collaborative Chronic Care Network Resource Report Resource Website |
Collaborative Chronic Care Network (RRID:SCR_003708) | C3N | data or information resource, organization portal, consortium, portal | Project designing, prototyping, optimizing, and evaluating a learning health system to improve clinical practice, patient self-management, and disease outcomes of patients with chronic illness. This open, peer production system combines the collective input of patients, clinicians and researchers. It combines large clinical data registries with patient entered data and makes them accessible and interactive. A platform allows researchers to design, test and implement new knowledge and innovations in patient care. To test their platform approach, C3N is working on a model of treating children with Inflammatory Bowel Disease using the ImproveCareNow Network of pediatric clinics. Following this demonstration phase, the goal is to apply the social, scientific and technical platform to transform the care of a variety of chronic illnesses. The C3N effort has the following goals: # Deploy and optimize an integrated set of engagement tools to make it easier for patients and care providers to collect and use the right information during the clinical encounter and in between visits. # Prototype novel interventions to re-design care delivery by promoting the development of tools for real-time and dynamic population management, "just-in time" scheduling of visits, virtual clinic visits, and measuring the impact of these interventions on health, care, and cost. # Pilot and deploy patient-focused technology to improve the flow of data between patients, clinicians and scientists to enable faster learning and improvement. | pediatric, child, young human, chronic illness care, patient outcome, clinical, health care, treatment, gastroenterology, collaboration, prototype, intervention | is listed by: Consortia-pedia | NIDDK R01DK085719 | nlx_157875 | SCR_003708 | C3N Project | 2026-02-16 09:46:05 | 0 | |||||||
|
AddNeuroMed Resource Report Resource Website 50+ mentions |
AddNeuroMed (RRID:SCR_003819) | AddNeuroMed | organization portal, database, consortium, portal, data or information resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 9,2023. Project portal for a cross European study designed to find biomarkers, or tests, for Alzheimer's disease. Its objectives are to produce and improve experimental models of Alzheimer's for biomarker discovery and to identify a biomarker for Alzheimer's disease suitable for diagnosis, prediction, and monitoring disease progression for use in clinical trials and in clinical practice. The baseline dataset database was scheduled to be completed and locked in 2008 and become available to researchers by 2009. Requests to access the data will be reviewed by the scientific projects committee. | biomarker, test, diagnostic, device, clinical, animal model, clinical trial, pre-clinical, consortium, disease progression, mri, proteomics, genomics, lipidomics, neuroimaging, mouse model, rat model, drosophila model, FASEB list |
is listed by: Consortia-pedia is related to: Innovative Medicines Initiative is related to: University of Eastern Finland at Kuopio; Kuopio; Finland is related to: University of Perugia; Perugia; Italy is related to: Aristotle University of Thessaloniki; Thessaloniki; Greece is related to: King's College London; London; United Kingdom is related to: University of Lodz; Lodz; Poland has parent organization: Innovative Medicines Initiative has parent organization: King's College London; London; United Kingdom |
European Union ; EFPIA |
PMID:19906259 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158122 | SCR_003819 | The AddNeuroMed Study | 2026-02-16 09:46:07 | 77 | |||||
|
MRC Cognition and Brain Sciences Unit Resource Report Resource Website 10+ mentions |
MRC Cognition and Brain Sciences Unit (RRID:SCR_003818) | CBU | data or information resource, department portal, organization portal, portal | Unit studying human cognition and the brain with about 90 researchers and postgraduate students investigating topics such as attention, emotion, language and memory. They are developing new treatments for depression, improving hearing through cochlear implants, and helping children to overcome memory problems. With a large collection of scientists engaged in both basic and translational research on the mind and brain, the Unit provides an exceptional training and academic environment that benefits postgraduate students and researchers at all levels. A significant part of their research makes use of brain imaging and they have excellent on-site facilities for magnetic resonance imaging (MRI) magnetoencephalography (MEG) and electroencephalography (EEG). They also have clinical facilities at Addenbrooke's Hospital. The Unit has close links both with the hospital and with Cambridge University. | cognition, attention, language, memory, emotion, behavior, neuroimaging, computer modelling, brain, depressive disorder, hearing, cochlear implant, child, clinical, mri, magnetoencephalography, eeg, ear, cochlea |
has parent organization: University of Cambridge; Cambridge; United Kingdom is parent organization of: CBU Imaging Wiki is parent organization of: Kymata Atlas |
MRC | nlx_158118, grid.415036.5, Wikidata: Q5141152, ISNI: 0000 0001 2177 2032 | https://ror.org/055bpw879 | SCR_003818 | Cognition and Brain Sciences Unit | 2026-02-16 09:46:15 | 31 | ||||||
|
Predictive Safety Testing Consortium Resource Report Resource Website |
Predictive Safety Testing Consortium (RRID:SCR_003727) | PSTC | data or information resource, organization portal, consortium, portal | A public-private partnership to identify new and improved translational safety testing methods for use in nonclinical and clinical studies and submit them for formal regulatory qualification by the FDA (Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Japanese Pharmaceutical and Medical Devices Agency). The current 19 corporate members of the consortium share internal experience with nonclinical and clinical safety biomarkers in six working groups: cardiac hypertrophy, nephrotoxicity, hepatotoxicity, skeletal myopathy, testicular toxicity, and vascular injury. The ultimate goal of the consortium is to improve the current approach to drug safety testing and offer assurance to the drug developers that these approaches will be accepted by the regulatory authorities in their drug development programs. Through PSTC, members are able to share their expertise, resources, data, and internally developed approaches in a neutral, precompetitive, confidential environment. There are more than 250 participating scientists and C-Path serves as the trusted third party, leading the collaborative process by collecting and summarizing the data, and leading the interactions with global health authorities. | drug, consortium, safety testing, safety, drug safety, clinical, nonclinical, biomarker, kidney, testicular, liver, skeletal muscle, vascular, drug development, biomarker assay |
is listed by: Consortia-pedia is related to: European Medicines Agency is related to: Pharmaceuticals and Medical Devices Agency has parent organization: Critical Path Institute; Arizona; USA is parent organization of: PSTC Nephrotoxicity Biomarkers |
annual dues ; in-kind contributions ; U.S. Food and Drug Administration |
nlx_157912 | SCR_003727 | 2026-02-16 09:46:14 | 0 | ||||||||
|
I-SPY 2 TRIAL Resource Report Resource Website 1+ mentions |
I-SPY 2 TRIAL (RRID:SCR_003713) | I-SPY 2, ISPY2, I-SPY2 | organization portal, clinical trial, consortium, portal, data or information resource | A collaboration to test an adaptive clinical trial model that would assess the efficacy of a candidate therapeutic earlier than traditional clinical trials, potentially enabling drugs to be developed and approved using fewer patients, less time and fewer resources. This trial focuses on women with newly diagnosed locally advanced breast cancer to test whether adding investigational drugs to standard chemotherapy is better than standard chemotherapy alone. It uses genetic and biological markers from individual patients' tumors to screen several promising new treatments simultaneously and allows doctors to quickly measure the effectiveness of the treatment prior to removing the tumor. The experimental adaptive trial design uses patient outcomes to immediately inform treatment options for subsequent trial participants. The trial has 5 components that differentiate it from conventional clinical trial models. # I-SPY2 uses tissue and imaging biomarkers from individual cancer patients' tumors to determine eligibility, guide/screen promising new treatments and identify which treatments are most effective in specific tumor subtypes. # The trial's adaptive design allows the Team to learn as they go, enabling researchers to use data from patients early in the trial to guide decisions about which treatments might be more useful for patients who enter the trial earlier. I-SPY2 provides a scientific basis for researchers to eliminate ineffective treatments and graduate effective treatments more quickly. # The neoadjuvant treatment approach - in which chemotherapy is given to patients prior to surgery - allow the team to evaluate tumor response with MRI before removal. This approach is safe as treating after surgery, allowing tumors to shrink, and more importantly, it enables critical learning early on about how well treatments work. # The ability for the team to screen multiple drug candidates developed by multiple companies. New agents will be selected and added as those used initially and either graduate to Phase III, or are dropped, based on their efficacy in targeted patients. # The trials informatics system allows data to be collected, verified, and shared in real-time. This allows data to be assessed early and in an integrated fashion - with an aim to enhance and encourage collaboration | drug, chemotherapy, oncology, female, drug development, biomarker, imaging, tissue, mri, paclitaxel, trastuzumab, anthracycline, cyclophosphamide, clinical |
is listed by: Consortia-pedia has parent organization: Biomarkers Consortium |
non-profit foundations ; Safeway Foundation ; pharmaceutical companies ; Johnson and Johnson ; Amgen ; Lilly ; Pfizer ; Eisai ; Genentech ; Quintiles TransNational Corp |
nlx_157884 | SCR_003713 | Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2, ISPY-2 Clinical Trials | 2026-02-16 09:46:10 | 4 | |||||||
|
DC-Research.eu - Dendritic Cell Research Knowledge Portal Resource Report Resource Website |
DC-Research.eu - Dendritic Cell Research Knowledge Portal (RRID:SCR_004200) | DC-RESEARCH.EU | data access protocol, database, people resource, software resource, data or information resource | An open knowledge resource for the dendritic cell research community, this index of research assets and expertise is designed to support translational research by providing annotations and interrelations on materials, datasets, tools, techniques, persons and organizations. The content of DC-RESEARCH.EU can be accessed by researchers through its website and can be accessed programmatically: the information in DC-RESEARCH.EU is represented through machine processable languages, proper of the Semantic Web (RDF and RDFa). To submit to the dc-thera directory please contact: dc-research_at_leafbioscience.com | biomaterial, tool, organization, clinical, imaging, preclinical, proteomics, signalling, transcriptomics, clinical protocol, laboratory protocol, protocol, post-clinical protocol, standard operating procedure, treatment protocol, dentrite, annotation, dendritic cell, rdf, data set, software resource, document, publication, clinical study dataset, imaging dataset, preclinical study dataset, proteomics dataset, signalling dataset, transcriptomic dataset, algorithm, factual, device, method, experimental protocol, directory | DC-THERA | Open, The community can contribute to this resource | nlx_143631 | SCR_004200 | 2026-02-16 09:46:17 | 0 | ||||||||
|
TRANSFoRm Data Integration Models Resource Report Resource Website |
TRANSFoRm Data Integration Models (RRID:SCR_003892) | data or information resource, standard specification, narrative resource, report | A set of three models, which in conjunction with the semantic mediator enables the execution of queries formulated through the eligibility representation of the Clinical research information model (WT6.4). An ontology-driven mechanism was developed to enable linkage and integration of phenotypic and genotypic data from multiple distributed data sources. It makes use of the Clinical Data Integration Model (CDIM, WT6.5), the Data Source Model (DSM, WT6.6) and the CDIM-DSM mapping model (WT6.6). Queries formulated through the CDIM and vocabulary service (WT7.2) are translated to local queries by the mediator using the individual source instances of the DSM and CDIM-DSM models. | clinical, model |
uses: TRANSFoRm Clinical Data Integration Model uses: TRANSFoRm Clinical Research Information Model has parent organization: TRANSFoRm |
nlx_158223 | SCR_003892 | Data Integration Model | 2026-02-16 09:46:17 | 0 | |||||||||
|
ONE Study Resource Report Resource Website 10+ mentions |
ONE Study (RRID:SCR_003886) | ONE Study | data or information resource, organization portal, consortium, portal | Consortium aiming to produce regulatory T cells that are compatible with a kidney transplant patient''''s immune system, as a measure to suppress the body''''s natural immune response against a transplanted organ. If successful, this approach will reduce a transplantation patient''''s life-long dependency on immune suppressing drugs, many of which are often associated with undesirable side effects and can limit the patient''''s daily routine. The consortium goals are to develop and conduct clinical trials of various immunoregulatory T-cell-based products in organ transplantation recipients, allowing a direct comparison of the safety, clinical practicality and therapeutic efficacy of each cell type. The central focus of the project is to: # Production and manufacture of distinct populations of hematopoietic immunoregulatory T cells # Comparatively study the tolerogenic characteristics of these regulatory cell types # Test these cell therapy products side by side in a clinical trial living donor renal transplant recipients The first workstream will work with different T regulatory cell, tolerogenic DC and suppressive macrophage cell products that are currently in development. In addition to these therapeutics, another goal of this workstream is to develop a cell tracking technology that assesses pharmacodynamics and pharmacokinetics of these cell-based therapies. The second workstream is focused on designing and conducting a cell therapy based clinical trial in renal transplantation, taking into consideration ethics, concurrent immunosuppressive drug use, state-of-the-art immune monitoring, innovative all-in-one data capturing systems, and pharmacovigilance. The goal is to have a comparative evaluation of hematopoietic cell therapy safety in renal transplantation. The third workstream aims to learn more about the specific comparative characteristics of suppressive cell types and to use this knowledge to improve later trial designs and foster novel ideas for new or improved suppressive / tolerogenic cell population. | immune response, organ transplant, kidney, clinical trial, cell therapy, clinical, immune system, tool development, basic research, healthcare, drug development, transplant surgery, immunosuppression, hematopoietic immunoregulatory cell |
is listed by: Consortia-pedia is related to: University of Regensburg; Bavaria; Germany is related to: King's College London; London; United Kingdom is related to: University of Oxford; Oxford; United Kingdom is related to: Charite - Universitatsmedizin Berlin; Berlin; Germany is related to: Fondazione Centro San Raffaele; Milan; Italy is related to: Loughborough University; Loughborough; United Kingdom is related to: University of Wisconsin-Madison; Wisconsin; USA is related to: University of California at San Francisco; California; USA is related to: Miltenyi Biotec is related to: Electro Scientific Industries is related to: Beckman Coulter is related to: KOEHLER eClinical is related to: Pharmatching is related to: ALTA |
European Union FP7 | nlx_158215 | SCR_003886 | A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation, The ONE Study - A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation, The ONE Study | 2026-02-16 09:46:09 | 21 | |||||||
|
TRANSFoRm Clinical Data Integration Model Resource Report Resource Website |
TRANSFoRm Clinical Data Integration Model (RRID:SCR_003885) | CDIM | ontology, data or information resource, controlled vocabulary | A global mediation model expressed as an ontology for use in the primary care domain. It uses a realist approach employing Basic Formal Ontology (BFO v1.1) as an upper ontology. Other ontologies were imported or specialized to give deeper definition to the concepts in the domain. These included OGMS, IAO and VSO. The CDIM ontology includes concepts that are especially important to primary care (e.g. episode of care or reason for encounter), but also others to handle temporality in queries (e.g. the start and beginning of processes). The owl file provided for download is the merged file created directly in Prot��g�� through the Refactor/Merge ontologies tool in order to facilitate the load of CDIM in LexEVS for use in the unified interoperability framework. | clinical, primary care, owl, interoperability |
uses: Ontology for General Medical Science uses: Information Artifact Ontology uses: Vital Signs Ontology is used by: TRANSFoRm Data Integration Models has parent organization: TRANSFoRm |
nlx_158222 | SCR_003885 | CDIM ontology, Clinical Data Integration Model | 2026-02-16 09:46:15 | 0 | ||||||||
|
ORBITO Resource Report Resource Website 1+ mentions |
ORBITO (RRID:SCR_003876) | ORBITO | data or information resource, organization portal, consortium, portal | Project that aims to increase understanding of how orally-administered drugs are taken up from the gastrointestinal tract into the body, and apply this knowledge to create new laboratory tests and computer models that will better predict the performance of these drugs in patients over a range of clinically relevant conditions. The integration of in vitro and in silico approaches will provide a biopharmaceutics toolkit, validated using clinical data, to accelerate drug development. Ultimately, the project will help to facilitate and speed up the formulation development process and significantly reduce the need for animal experiments in this area as well as for human clinical studies in the future. For patients, the main benefit will be in the form of high quality medicines where the dose required is well calculated and is released in a way that consistently provides an optimal clinical effect. | drug, drug development, tool development, computer model, drug absorption, oral drug, gastrointestinal tract, clinical, in vivo, in vitro, in silico, biopharmaceutics, dose, drug performance |
is listed by: Consortia-pedia is related to: AbbVie is related to: Janssen Research and Development is related to: Merck is related to: Orion is related to: Pfizer Animal Genetics is related to: Uppsala University; Uppsala; Sweden is related to: University of Copenhagen; Copenhagen; Denmark is related to: University of Greifswald; Mecklenburg-Vorpommern; Germany is related to: Goethe University Frankfurt am Main; Hessen; Germany is related to: Johannes Gutenberg University Mainz; Rhineland-Palatinate; Germany is related to: Catholic University of Leuven; Flemish Brabant; Belgium is related to: Medical Products Agency; Uppsala; Sweden is related to: University of Athens; Athens; Greece is related to: TNO is related to: University of Manchester; Manchester; United Kingdom is related to: University of Strathclyde; Glasgow; United Kingdom is related to: Simcyp is related to: Sirius Analytical is related to: Simulations Plus has parent organization: Uppsala University; Uppsala; Sweden |
Innovative Medicines Initiative ; EFPIA |
nlx_158204 | SCR_003876 | orbito - Innovative Tools for Oral Biopharmaceutics, Oral biopharmaceutics tools (ORBITO) | 2026-02-16 09:46:09 | 7 | |||||||
|
Brighton Collaboration Resource Report Resource Website 10+ mentions |
Brighton Collaboration (RRID:SCR_004089) | BC | community building portal, portal, controlled vocabulary, data or information resource, protocol | A non-profit partnership and global research network providing high quality vaccine safety information. Their mission is to enhance the science of vaccine research by providing standardized, validated, and objective methods for monitoring safety profiles and benefit to risk ratios of vaccines. Products and services to promote high quality vaccine safety research include: * Standardized case definitions of adverse events following immunization * Guidelines for collection, analysis, and presentation of vaccine safety data * Template protocols for vaccine safety research * Automatic Case Classification Tool (ABC tool) * Library of vaccine safety publications * Links to high quality vaccine safety resources * Vaccine Safety Quarterly - Newsletter | vaccine, safety, vaccine safety, adverse event, immunization, clinical | is related to: EMIF | Adverse event following immunization | Account required | nlx_158550 | SCR_004089 | Brighton | 2026-02-16 09:46:16 | 26 | ||||||
|
American Society of Diagnostic and Interventional Nephrology Resource Report Resource Website 1+ mentions |
American Society of Diagnostic and Interventional Nephrology (RRID:SCR_003968) | ASDIN | data or information resource, community building portal, training resource, portal | Society that aims to promote the proper application of new and existing procedures to improve the care of patients with kidney disease. They promote education, research, public policy and clinical practice initiatives relating to diagnostic and interventional procedures. ASDIN works closely with other societies and programs to achieve its goals. All professionals involved in the care of patients with kidney disease are welcome to join and become active in the Society. Activities of the Society include: * the establishment of practice standards, * certification of physicians in specific procedures, * accreditation of training programs in specific procedures, * development of training tools and techniques, * sponsoring symposia and training courses, * and the dissemination of information through periodic meetings and through print and other media. | nephrology, diagnostic, intervention, clinical, kidney | is related to: Kidney Health Initiative | Kidney disease | nlx_158373 | SCR_003968 | American Society of Diagnostic & Interventional Nephrology | 2026-02-16 09:46:15 | 3 | |||||||
|
Asia Training Consortium Resource Report Resource Website |
Asia Training Consortium (RRID:SCR_004014) | ATC | training resource, organization portal, consortium, portal, data or information resource, short course | Consortium of pharmaceutical companies and clinical research organizations, plus one regional association, that are pooling their resources to deliver quality training courses for clinical research professionals in the Asia Pacific region. The collaborative training initiatives aim to resolve issues of redundant and duplicate trainings, less than optimal class sizes and lower than ideal training frequencies, all of which are prevalent in the region. ATC also hopes to significantly enhance the number and quality of professionals to meet the resource demands of the globalized industry. The first target audience would be clinical trial investigators and clinical trial management staff - with priorities provided to clinical trial associates, clinical trial project managers, and clinical research managers. As of 2014, 900 days of ATC courses have been taught in classrooms throughout Asia. The ATC''s Foundations of Clinical Project Management is a regularly offered in Shanghai and is available on-line in English and Mandarin. | drug development, tool development, drug, healthcare, pharmaceutical, clinical, clinical research organization, clinical project management, project management, clinical trial |
is listed by: Consortia-pedia has parent organization: Merck |
Annual dues | nlx_158433 | SCR_004014 | 2026-02-16 09:46:15 | 0 | ||||||||
|
EORTC Clinical Trials Resource Report Resource Website |
EORTC Clinical Trials (RRID:SCR_004011) | database, clinical trial, data or information resource, catalog | A database that contains information about EORTC (European Organisation for Research and Treatment of Cancer) clinical trials but also clinical trials from other organizations, in which EORTC has been/is participating. The protocol database may be browsed by EORTC Research Group, tumor site, treatment, or drug. | clinical, protocol | has parent organization: EORTC | Cancer | nlx_158511 | SCR_004011 | European Organisation for Research and Treatment of Cancer Clinical trials, EORTC protocol database | 2026-02-16 09:46:16 | 0 | ||||||||
|
JDRF Artificial Pancreas Project Consortium Resource Report Resource Website |
JDRF Artificial Pancreas Project Consortium (RRID:SCR_004010) | Artificial Pancreas Consortium | data or information resource, organization portal, consortium, portal | Consortium aiming to accelerate the development of systems for automated control of blood glucose in patients with diabetes. Consortium investigators seek to research and develop strategies, which can be commercialized, that will confer the long-term benefits of improved glycemic control by combining novel automated control algorithms and hormone therapies with continuous glucose monitors and pump devices. The field of closed-loop artificial pancreas research requires expert diabetologists partnering with expert mathematicians and engineers. Consortium investigators include endocrinologists and control theorists at research institutions in the US and in Europe. Many of the diabetes device manufacturers have also participated, providing pumps and sensors with enhanced capabilities that allow for closed-loop experiments to be performed. The goals of the consortium include: * Design, optimization, and clinical testing of multiple algorithmic approaches to closed-loop control * An in silico simulation platform, accepted by the FDA, for validating candidate closed-loop control algorithms in place of animal trials * Reusable templates for constructing the Investigational Device Exemption regulatory documents that must be approved by the FDA prior to any in-clinic, computer-assisted, closed-loop control research involving people * A modular software platform-the Artificial Pancreas System-with a protocol-independent user interface and hooks to incorporate an arbitrary control algorithm and control various continuous glucose monitors and pump devices * A secure consortium Web site with a central repository for experimental data and interfaces to submit candidate control algorithms for centralized validation and to upload or download clinical data sets * the first outpatient studies of an overnight controller * the first outpatient studies of a hypoglycemia minimization strategy * the development and testing of a modular treat-to-range closed-loop approach * multiple studies of dual hormone (insulin and glucagon) devices and a means to improve insulin kinetics Ongoing and recently completed in-clinic studies at the end of 2011 include investigations into hypoglycemia prediction and avoidance as well as fully-automated closed-loop control investigations using MPC and PID/PD-based algorithms. The most recent developments include the first-ever feasibility trials of portable, outpatient-based closed-loop control systems. | device development, product development, device, blood glucose, hypoglycemia, glucose monitor, pump device, glycemic control, insulin, glucagon, closed-loop control, clinical |
is listed by: Consortia-pedia is related to: Juvenile Diabetes Research Foundation is related to: Critical Path Initiative has parent organization: Jaeb Center for Health Research |
JDRF ; NIDDK |
nlx_158431 | SCR_004010 | Artificial Pancreas Project Consortium, JDRF/NIDDK Artificial Pancreas Project Consortium | 2026-02-16 09:46:18 | 0 | |||||||
|
SHRINE Resource Report Resource Website 1+ mentions |
SHRINE (RRID:SCR_006293) | SHRINE | software application, source code, software resource | Software providing a scalable query and aggregation mechanism that enables federated queries across many independently operated patient databases. This platform enables clinical researchers to solve the problem of identifying sufficient numbers of patients to include in their studies by querying across distributed hospital electronic medical record systems. Through the use of a federated network protocol, SHRINE allows investigators to see limited data about patients meeting their study criteria without compromising patient privacy. This software should greatly enable population-based research, assessment of potential clinical trials cohorts, and hypothesis formation for followup study by combining the EHR assets across the hospital system. In order to obtain the maximum number of cases representing the study population, it is useful to aggregate patient facts across as many sites as possible. Cutting across institutional boundaries necessitates that each hospital IRB remain in control, and that their local authority is recognized for each and every request for patient data. The independence, ownership, and legal responsibilities of hospitals predetermines a decentralized technical approach, such as a federated query over locally controlled databases. The application comes with the SHRINE Core Ontology but it can be used with any ontology, even one that is disease specific. The Core Ontology is designed to enable the widest range of studies possible using facts gathered in the EMR during routine patient care. SHRINE allows multiple ontologies to be used for different research purposes on the same installed systems. | software network, clinical database, data sharing, clinical, medical record, federated, platform, network |
is related to: i2b2 Cross-Institutional Clinical Translational Research project is related to: i2b2 Research Data Warehouse has parent organization: Harvard Medical School; Massachusetts; USA |
Informatics for Integrating Biology and the Bedside ; NLM 5 U54 LM008748; NCRR 1 UL1 RR025758-01 |
PMID:19567788 | Available under a BSD3 Open unspecified license Software license. | nlx_151949 | SCR_006293 | Shared Health Research Informatics NEtwork | 2026-02-15 09:19:12 | 8 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
